Other Proteins

Recombinant human complex made of USP1 (ubiquitin specific peptidase 1), encompassing amino acids 2-785(end), and UAF1 (ubiquitin specific peptidase 1), encompassing amino acids 1-677 (end). The USP1 construct contains an N-terminal FLAG-Tag and the UAF1 construct contains a C-terminal His-tag (6xHis). The proteins were co-expressed and purified as a complex. Two mutations of interest are present in USP1, G670A, G671A.

Alpha-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in brain, specifically in cerebellum, thalamus, neocortex, hippocampus, and striatum regions. Other tissues express α-Synuclein at very low levels. The physiological role of α-synuclein is not yet well understood. However, the presence of imperfect KTKEGV lipid interacting repeats suggests that it may be involved in synaptic vesicle homeostasis.

Alpha-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in brain, specifically in cerebellum, thalamus, neocortex, hippocampus, and striatum regions. Other tissues express α-Synuclein at very low levels. The physiological role of α-synuclein is not yet well understood. However, the presence of imperfect KTKEGV lipid interacting repeats suggests that it may be involved in synaptic vesicle homeostasis.

Recombinant human MMP-1 protein derived from E.coli

GMP Grade Recombinant Human GM-CSF/CSF2 Protein is produced in GMP compliance facility designed under ISO 13485:2016, cGMP, and ISO 17025:2017 certifications utilizing animal-orignal free and beta-lactam free materials under stringent quality management.

GMP Grade Recombinant Human GM-CSF/CSF2 Protein is produced in GMP compliance facility designed under ISO 13485:2016, cGMP, and ISO 17025:2017 certifications utilizing animal-orignal free and beta-lactam free materials under stringent quality management.

Recombinant human VEGFR1 (vascular endothelial growth factor receptor 1), also known as FLT1, encompassing amino acids 27-756 corresponding to the extracellular domain. This construct contains a C-terminal Fc domain of human IgG1 followed by an Avi-tag™. This protein was affinity purified.

Recombinant human VEGFR1 (vascular endothelial growth factor receptor 1), also known as FLT1, encompassing amino acids 27-756 corresponding to the extracellular domain. This construct contains a C-terminal Fc domain of human IgG1 followed by an Avi-tag™. This protein was affinity purified.

Recombinant human VEGFR1 (vascular endothelial growth factor receptor 1), also known as FLT1, encompassing amino acids 27-756 corresponding to the extracellular domain. This construct contains a C-terminal Fc domain of human IgG1 followed by an Avi-tag™. This protein was affinity purified.